Canada markets closed

Ocuphire Pharma, Inc. (OCUP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9900+0.1400 (+7.57%)
At close: 04:00PM EDT
1.9400 -0.05 (-2.51%)
After hours: 07:17PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
19,049
19,049
39,850
589
0
Operating Expenses
Research Development
17,653
17,653
14,355
15,173
6,648
Selling General and Administrative
11,959
11,959
7,269
8,121
2,818
Total Operating Expenses
29,612
29,612
21,624
23,294
9,466
Operating Income or Loss
-10,563
-10,563
18,226
-22,705
-9,466
Interest Expense
0
0
9
2
6,847
Total Other Income/Expenses Net
1,917
1,917
-14
-33,986
-8,307
Income Before Tax
-9,974
-9,974
18,203
-56,693
-24,620
Income Tax Expense
12
12
315
0
0
Income from Continuing Operations
-9,986
-9,986
17,888
-56,693
-24,620
Net Income
-9,986
-9,986
17,888
-56,693
-24,620
Net Income available to common shareholders
-9,986
-9,986
17,888
-56,693
-24,620
Basic EPS
1.47
-
0.90
-3.82
-5.28
Diluted EPS
1.44
-
0.87
-3.82
-5.28
Basic Average Shares
21,042
-
19,931
14,853
4,661
Diluted Average Shares
21,708
-
20,597
14,853
4,661